We’re dedicated to
Identifying people at risk of dementia, Parkinson’s Disease and multiple sclerosis, and finding new ways to prevent the diseases.
The difference we’re making
- Enabling large-scale trials to find the people most at risk and investigate whether preventative treatments work
- Facilitating research with potential global health significance, which could help hundreds of thousands of people age more healthily
- Potentially easing the strain on the NHS by reducing the number of patients with degenerative neurological diseases
- Researching how we can use simple treatments to stop these disorders, such as:
- Can nicotine lower your risk of developing Parkinson’s Disease?
- Can vaccinating against the Epstein Barr Virus prevent multiple sclerosis?
- Can aspirin reduce the effects of dementia?
Funding extraordinary healthcare
A report for Alzheimer’s Research UK predicts that of people born this year, one in three will develop dementia. The socioeconomic burden of this and other major neurodegenerative diseases cannot be understated. By the time the disease presents itself, irreversible damage has already been done. Early identification of individuals at risk is therefore critical in order to prevent the worst effects of these diseases.